1
|
Lane JM, Russell L and Khan SN:
Osteoporosis. Clin Orthop Relat Res 139-150, 2000.
|
2
|
McCormick RK: Osteoporosis: Integrating
biomarkers and other diagnostic correlates into the management of
bone fragility. Altern Med Rev. 12:113–145. 2007.PubMed/NCBI
|
3
|
De Martinis M, Sirufo MM and Ginaldi L:
Osteoporosis: Current and emerging therapies targeted to
immunological checkpoints. Curr Med Chem: Jul 30, 2019 (Epub ahead
of print). doi: 10.2174/0929867326666190730113123.
|
4
|
Aggarwal BB, Shishodia S, Takada Y,
Banerjee S, Newman RA, Bueso-Ramos CE and Price JE: Curcumin
suppresses the paclitaxel-induced nuclear factor-kappaB pathway in
breast cancer cells and inhibits lung metastasis of human breast
cancer in nude mice. Clin Cancer Res. 11:7490–7498. 2005.PubMed/NCBI View Article : Google Scholar
|
5
|
Datta HK, Ng WF, Walker JA, Tuck SP and
Varanasi SS: The cell biology of bone metabolism. J Clin Pathol.
61:577–587. 2008.PubMed/NCBI View Article : Google Scholar
|
6
|
Khosla S, Oursler MJ and Monroe DG:
Estrogen and the skeleton. Trends Endocrinol Metab. 23:576–581.
2012.PubMed/NCBI View Article : Google Scholar
|
7
|
Adori M, Kiss E, Barad Z, Barabás K,
Kiszely E, Schneider A, Kövesdi D, Sziksz E, Abrahám IM, Matkó J
and Sármay G: Estrogen augments the T cell-dependent but not the
T-independent immune response. Cell Mol Life Sci. 67:1661–1674.
2010.PubMed/NCBI View Article : Google Scholar
|
8
|
Zhang N, Gui Y, Qiu X, Tang W, Li L, Gober
HJ, Li D and Wang L: DHEA prevents bone loss by suppressing the
expansion of CD4(+) T cells and TNFa production in the OVX-mouse
model for postmenopausal osteoporosis. Biosci Trends. 10:277–287.
2016.PubMed/NCBI View Article : Google Scholar
|
9
|
Faienza MF, Ventura A, Marzano F and
Cavallo L: Postmenopausal osteoporosis: The role of immune system
cells. Clin Dev Immunol. 2013(575936)2013.PubMed/NCBI View Article : Google Scholar
|
10
|
Eastell R, O'Neill TW, Hofbauer LC,
Langdahl B, Reid IR, Gold DT and Cummings SR: Postmenopausal
osteoporosis. Nat Rev Dis Primers. 2(16069)2016.PubMed/NCBI View Article : Google Scholar
|
11
|
Li JY, Tawfeek H, Bedi B, Yang X, Adams J,
Gao KY, Zayzafoon M, Weitzmann MN and Pacifici R: Ovariectomy
disregulates osteoblast and osteoclast formation through the T-cell
receptor CD40 ligand. Proc Natl Acad Sci USA. 108:768–773.
2011.PubMed/NCBI View Article : Google Scholar
|
12
|
Song H, Li X, Zhao Z, Qian J, Wang Y, Cui
J, Weng W, Cao L, Chen X, Hu Y and Su J: Reversal of osteoporotic
activity by endothelial cell-secreted bone targeting and
biocompatible exosomes. Nano Lett. 19:3040–3048. 2019.PubMed/NCBI View Article : Google Scholar
|
13
|
Chen X, Zhi X, Wang J and Su J: RANKL
signaling in bone marrow mesenchymal stem cells negatively
regulates osteoblastic bone formation. Bone Res.
6(34)2018.PubMed/NCBI View Article : Google Scholar
|
14
|
Uehara IA, Soldi LR and Silva MJB: Current
perspectives of osteoclastogenesis through estrogen modulated
immune cell cytokines. Life Sci. 256(117921)2020.PubMed/NCBI View Article : Google Scholar
|
15
|
Sang C, Zhang J, Zhang Y, Chen F, Cao X
and Guo L: TNF-α promotes osteoclastogenesis through JNK
signaling-dependent induction of Semaphorin3D expression in
estrogen-deficiency induced osteoporosis. J Cell Physiol.
232:3396–3408. 2017.PubMed/NCBI View Article : Google Scholar
|
16
|
Roggia C, Gao Y, Cenci S, Weitzmann MN,
Toraldo G, Isaia G and Pacifici R: Up-regulation of TNF-producing T
cells in the bone marrow: A key mechanism by which estrogen
deficiency induces bone loss in vivo. Proc Natl Acad Sci USA.
98:13960–13965. 2001.PubMed/NCBI View Article : Google Scholar
|
17
|
Li J, Wang Q, Yang R, Zhang J, Li X, Zhou
X and Miao D: BMI-1 mediates estrogen-deficiency-induced bone loss
by inhibiting reactive oxygen species accumulation and T cell
activation. J Bone Miner Res. 32:962–973. 2017.PubMed/NCBI View Article : Google Scholar
|
18
|
Bi H, Ming L, Cheng R, Luo H, Zhang Y and
Jin Y: Liver extracellular matrix promotes BM-MSCs hepatic
differentiation and reversal of liver fibrosis through activation
of integrin pathway. J Tissue Eng Regen Med. 11:2685–2698.
2017.PubMed/NCBI View Article : Google Scholar
|
19
|
Phinney DG: Biochemical heterogeneity of
mesenchymal stem cell populations: Clues to their therapeutic
efficacy. Cell Cycle. 6:2884–2889. 2007.PubMed/NCBI View Article : Google Scholar
|
20
|
Bi H and Jin Y: Current progress of skin
tissue engineering: Seed cells, bioscaffolds, and construction
strategies. Burns Trauma. 1:63–72. 2013.PubMed/NCBI View Article : Google Scholar
|
21
|
Kim KI, Park S and Im GI: Osteogenic
differentiation and angiogenesis with cocultured adipose-derived
stromal cells and bone marrow stromal cells. Biomaterials.
35:4792–4804. 2014.PubMed/NCBI View Article : Google Scholar
|
22
|
Pilz GA, Ulrich C, Ruh M, Abele H, Schäfer
R, Kluba T, Bühring HJ, Rolauffs B and Aicher WK: Human term
placenta-derived mesenchymal stromal cells are less prone to
osteogenic differentiation than bone marrow-derived mesenchymal
stromal cells. Stem Cells Dev. 20:635–646. 2011.PubMed/NCBI View Article : Google Scholar
|
23
|
Gimble JM and Nuttall ME: The relationship
between adipose tissue and bone metabolism. Clin Biochem.
45:874–879. 2012.PubMed/NCBI View Article : Google Scholar
|
24
|
Singh A, Mehdi AA, Srivastava RN and Verma
NS: Immunoregulation of bone remodelling. Int J Crit Illn Inj Sci.
2:75–81. 2012.PubMed/NCBI View Article : Google Scholar
|
25
|
Liu Y, Wang L, Kikuiri T, Akiyama K, Chen
C, Xu X, Yang R, Chen W, Wang S and Shi S: Mesenchymal stem
cell-based tissue regeneration is governed by recipient T
lymphocytes via IFN-γ and TNF-α. Nat Med. 17:1594–1601.
2011.PubMed/NCBI View Article : Google Scholar
|
26
|
Martinet L, Fleury-Cappellesso S,
Gadelorge M, Dietrich G, Bourin P, Fournié JJ and Poupot R: A
regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and
mesenchymal stem cells. Eur J Immunol. 39:752–762. 2009.PubMed/NCBI View Article : Google Scholar
|
27
|
Biver G, Wang N, Gartland A, Orriss I,
Arnett TR, Boeynaems JM and Robaye B: Role of the P2Y13 receptor in
the differentiation of bone marrow stromal cells into osteoblasts
and adipocytes. Stem Cells. 31:2747–2758. 2013.PubMed/NCBI View Article : Google Scholar
|
28
|
Yamaza T, Miura Y, Bi Y, Liu Y, Akiyama K,
Sonoyama W, Patel V, Gutkind S, Young M, Gronthos S, et al:
Pharmacologic stem cell based intervention as a new approach to
osteoporosis treatment in rodents. PLoS One.
3(e2615)2008.PubMed/NCBI View Article : Google Scholar
|
29
|
Eljaafari A, Tartelin ML, Aissaoui H,
Chevrel G, Osta B, Lavocat F and Miossec P: Bone marrow-derived and
synovium-derived mesenchymal cells promote Th17 cell expansion and
activation through caspase 1 activation: Contribution to the
chronicity of rheumatoid arthritis. Arthritis Rheum. 64:2147–2157.
2012.PubMed/NCBI View Article : Google Scholar
|
30
|
Duffy MM, Pindjakova J, Hanley SA,
McCarthy C, Weidhofer GA, Sweeney EM, English K, Shaw G, Murphy JM,
Barry FP, et al: Mesenchymal stem cell inhibition of T-helper 17
cell-differentiation is triggered by cell-cell contact and mediated
by prostaglandin E2 via the EP4 receptor. Eur J Immunol.
41:2840–2851. 2011.PubMed/NCBI View Article : Google Scholar
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
32
|
Duan L, Zhao H, Xiong Y, Tang X, Yang Y,
Hu Z, Li C, Chen S and Yu X: miR-16-2* Interferes with
WNT5A to Regulate Osteogenesis of Mesenchymal Stem Cells. Cell
Physiol Biochem. 51:1087–1102. 2018.PubMed/NCBI View Article : Google Scholar
|
33
|
Kelleher FC and O'Sullivan H: Monocytes,
macrophages, and osteoclasts in osteosarcoma. J Adolesc Young Adult
Oncol. 6:396–405. 2017.PubMed/NCBI View Article : Google Scholar
|
34
|
Kang SK, Shin IS, Ko MS, Jo JY and Ra JC:
Journey of mesenchymal stem cells for homing: Strategies to enhance
efficacy and safety of stem cell therapy. Stem Cells Int.
2012(342968)2012.PubMed/NCBI View Article : Google Scholar
|
35
|
D'Amelio P, Grimaldi A, Di Bella S,
Brianza SZM, Cristofaro MA, Tamone C, Giribaldi G, Ulliers D,
Pescarmona GP and Isaia G: Estrogen deficiency increases
osteoclastogenesis up-regulating T cells activity: A key mechanism
in osteoporosis. Bone. 43:92–100. 2008.PubMed/NCBI View Article : Google Scholar
|
36
|
Zhang JL, Qiu XM, Zhang N, Tang W, Gober
HJ, Li DJ and Wang L: BuShenNingXin decoction suppresses
osteoclastogenesis by modulating RANKL/OPG imbalance in the
CD4+ T lymphocytes of ovariectomized mice. Int J Mol
Med. 42:299–308. 2018.PubMed/NCBI View Article : Google Scholar
|
37
|
Aoki K, Saito H, Itzstein C, Ishiguro M,
Shibata T, Blanque R, Mian AH, Takahashi M, Suzuki Y, Yoshimatsu M,
et al: A TNF receptor loop peptide mimic blocks RANK ligand-induced
signaling, bone resorption, and bone loss. J Clin Invest.
116:1525–1534. 2006.PubMed/NCBI View Article : Google Scholar
|
38
|
Kudo O, Fujikawa Y, Itonaga I, Sabokbar A,
Torisu T and Athanasou NA: Proinflammatory cytokine
(TNFalpha/IL-1alpha) induction of human osteoclast formation. J
Pathol. 198:220–227. 2002.PubMed/NCBI View Article : Google Scholar
|
39
|
Algate K, Haynes DR, Bartold PM, Crotti TN
and Cantley MD: The effects of tumour necrosis factor-α on bone
cells involved in periodontal alveolar bone loss; osteoclasts,
osteoblasts and osteocytes. J Periodont Res. 51:549–566.
2016.PubMed/NCBI View Article : Google Scholar
|
40
|
Marahleh A, Kitaura H, Ohori F, Kishikawa
A, Ogawa S, Shen WR, Qi J, Noguchi T, Nara Y and Mizoguchi I: TNF-α
Directly Enhances Osteocyte RANKL Expression and Promotes
Osteoclast Formation. Front Immunol. 10(2925)2019.PubMed/NCBI View Article : Google Scholar
|
41
|
Du D, Zhou Z, Zhu L, Hu X, Lu J, Shi C,
Chen F and Chen A: TNF-α suppresses osteogenic differentiation of
MSCs by accelerating P2Y2 receptor in estrogen-deficiency induced
osteoporosis. Bone. 117:161–170. 2018.PubMed/NCBI View Article : Google Scholar
|
42
|
Kumar G and Roger PM: From Crosstalk
between Immune and Bone Cells to Bone Erosion in Infection. Int J
Mol Sci. 20(5154)2019.PubMed/NCBI View Article : Google Scholar
|
43
|
Lecarpentier Y, Schussler O, Sakic A,
Rincon-Garriz JM, Soulie P, Bochaton-Piallat ML and Kindler V:
Human bone marrow contains mesenchymal stromal stem cells that
differentiate in vitro into contractile myofibroblasts controlling
t lymphocyte proliferation. Stem Cells Int.
2018(6134787)2018.PubMed/NCBI View Article : Google Scholar
|
44
|
Lu X, Wang X, Nian H, Yang D and Wei R:
Mesenchymal stem cells for treating autoimmune dacryoadenitis. Stem
Cell Res Ther. 8(126)2017.PubMed/NCBI View Article : Google Scholar
|
45
|
Rios C, Garbayo E, Gomez LA, Curtis K,
D'Ippolito G and Schiller PC: Stem cells and their contribution to
tissue repair. Stem Cell Regenerative Medicine. 1:9–22. 2010.
|
46
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Re. 35:600–604. 2015.PubMed/NCBI View Article : Google Scholar
|
47
|
Cai TY, Zhu W, Chen XS, Zhou SY, Jia LS
and Sun YQ: Fibroblast growth factor 2 induces mesenchymal stem
cells to differentiate into tenocytes through the MAPK pathway. Mol
Med Rep. 8:1323–1328. 2013.PubMed/NCBI View Article : Google Scholar
|
48
|
Hwang JH, Byun MR, Kim AR, Kim KM, Cho HJ,
Lee YH, Kim J, Jeong MG, Hwang ES and Hong JH: Extracellular Matrix
Stiffness Regulates Osteogenic Differentiation through MAPK
Activation. PLoS One. 10(e0135519)2015.PubMed/NCBI View Article : Google Scholar
|
49
|
Huang RL, Yuan Y, Tu J, Zou GM and Li Q:
Opposing TNF-α/IL-1β- and BMP-2-activated MAPK signaling pathways
converge on Runx2 to regulate BMP-2-induced osteoblastic
differentiation. Cell Death Dis. 5(e1187)2014.PubMed/NCBI View Article : Google Scholar
|
50
|
Zhou S, Zilberman Y, Wassermann K, Bain
SD, Sadovsky Y and Gazit D: Estrogen modulates estrogen receptor
alpha and beta expression, osteogenic activity, and apoptosis in
mesenchymal stem cells (MSCs) of osteoporotic mice. J Cell Biochem
Suppl. 36:144–155. 2001.PubMed/NCBI View Article : Google Scholar
|
51
|
Yang N, Wang G, Hu C, Shi Y, Liao L, Shi
S, Cai Y, Cheng S, Wang X, Liu Y, et al: Tumor necrosis factor
alpha suppresses the mesenchymal stem cell osteogenesis promoter
miR-21 in estrogen deficiency-induced osteoporosis. J Bone Miner
Res. 28:559–573. 2013.PubMed/NCBI View Article : Google Scholar
|
52
|
Sang C, Zhang Y, Chen F, Huang P, Qi J,
Wang P, Zhou Q, Kang H, Cao X and Guo L: Tumor necrosis factor
alpha suppresses osteogenic differentiation of MSCs by inhibiting
semaphorin 3B via Wnt/β-catenin signaling in estrogen-deficiency
induced osteoporosis. Bone. 84:78–87. 2016.PubMed/NCBI View Article : Google Scholar
|